brentuximab vedotin (adcetris) Report issue

Biologics mAb ADC Orphan Drug FDA Approved FDA Accelerated Approval FDA
Back

Drug Pricing Summary

AUS PBS

$3609.0215

VA Big4

$5535.3900

VA FSS

$7586.1641

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
brentuximab vedotin 50 mg (INJECTION) $3609.0215 AUS PBS generic
  • Adcetris (1)
  • Takeda Pharmaceuticals Australia Pty Ltd
    brentuximab vedotin 50 mg / 10.5 mL (10.5 mL INJECTION) $5535.3900 VA Big4
  • ADCETRIS (1.0)
  • Seattle Genetics, Inc.
    brentuximab vedotin 50 mg / 10.5 mL (10.5 mL INJECTION) $7586.1641 VA FSS
  • ADCETRIS (1.0)
  • Seattle Genetics, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue